Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0ER9I
|
|||
| Former ID |
DNCL002029
|
|||
| Drug Name |
JNJ-40929837
|
|||
| Indication | Asthma [ICD-11: CA23; ICD-10: J45, J45.8; ICD-9: 493] | Phase 2 | [1] | |
| Company |
Janssen Research & Development
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C22H24N4O2S
|
|||
| Canonical SMILES |
CC(=O)NC1CC2CCC(C1)N2CC3=CC=C(C=C3)OC4=NC5=C(S4)C=CC=N5
|
|||
| InChI |
1S/C22H24N4O2S/c1-14(27)24-16-11-17-6-7-18(12-16)26(17)13-15-4-8-19(9-5-15)28-22-25-21-20(29-22)3-2-10-23-21/h2-5,8-10,16-18H,6-7,11-13H2,1H3,(H,24,27)/t16?,17-,18+
|
|||
| InChIKey |
QZOOKXDESAXLGB-AYHJJNSGSA-N
|
|||
| CAS Number |
CAS 1191044-42-4
|
|||
| PubChem Compound ID | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT01241422) A Study to Evaluate the Effectiveness of JNJ 40929837 for the Treatment of Asthma Using a Bronchial Allergen Challenge Model. U.S. National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.